Crosstalk Between Mucosal Inflammation and Bone Metabolism in Chronic Rhinosinusitis

키워드

참고문헌 (79)

1. Fokkens WJ, "EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists", Rhinology, 50(1), pp.1~12 (2012)
2. Hamilos DL, "Chronic rhinosinusitis: epidemiology and medical management", J Allergy Clin Immunol, 128(4), pp.693~707 (2011)
3. Schleimer RP, "Immunopathogenesis of chronic rhinosinusitis and nasal polyposis", Annu Rev Pathol, 12, pp.331~357 (2017)
4. Roza Khalmuratova, "Immune Cell Responses and Mucosal Barrier Disruptions in Chronic Rhinosinusitis", Immune Network, 17(1), pp.60~67 (2017), 대한면역학회[DOI]
5. Akdis CA, "Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology", J Allergy Clin Immunol, 131(6), pp.1479~1490 (2013)
6. Van Zele T, "Differentiation of chronic sinus diseases by measurement of inflammatory mediators", Allergy, 61(11), pp.1280~1289 (2006)
7. Brescia G, "Nasal polyposis pathophysiology: endotype and phenotype open issues", Am J Otolaryngol, 39(4), pp.441~444 (2018)
8. Cao PP, "Distinct immunopathologic characteristics of various types of chronic rhinosinusitis in adult Chinese", J Allergy Clin Immunol, 124(3), pp.478~484 (2009)
9. Kim SJ, "Changes in histological features of nasal polyps in a Korean population over a 17-year period", Otolaryngol Head Neck Surg, 149(3), pp.431~437 (2013)
10. Tikaram A, "Asian nasal polyps: a separate entity?", Med J Malaysia, 68(6), pp.445~447 (2013)
11. Cho SW, "Classification of chronic rhinosinusitis according to a nasal polyp and tissue eosinophilia:limitation of current classification system for Asian population", Asia Pac Allergy, 7(3), pp.121~130 (2017)
12. Snidvongs K, "Osteitis in chronic rhinosinusitis", Curr Allergy Asthma Rep, 19(5), pp.24~ (2019)
13. Bhandarkar ND, "Osteitis in chronic rhinosinusitis: a review of the literature", Int Forum Allergy Rhinol, 3(5), pp.355~363 (2019)
14. Snidvongs K, "Osteitis is a misnomer: a histopathology study in primary chronic rhinosinusitis", Int Forum Allergy Rhinol, 4(5), pp.390~396 (2014)
15. Lee JT, "The incidence of concurrent osteitis in patients with chronic rhinosinusitis: a clinicopathological study", Am J Rhinol, 20(3), pp.278~282 (2006)
16. Sacks PL, "The impact of neo-osteogenesis on disease control in chronic rhinosinusitis after primary surgery", Int Forum Allergy Rhinol, 3(10), pp.823~827 (2013)
17. Snidvongs K, "Osteitic bone: a surrogate marker of eosinophilia in chronic rhinosinusitis", Rhinology, 50(3), pp.299~305 (2012)
18. Georgalas C, "Global Osteitis Scoring Scale and chronic rhinosinusitis: a marker of revision surgery", Clin Otolaryngol, 35(6), pp.455~461 (2010)
19. Cho SH, "CT analysis and histopathology of bone remodeling in patients with chronic rhinosinusitis", Otolaryngol Head Neck Surg, 135(3), pp.404~408 (2006)
20. Biedlingmaier JF, "Histopathology and CT analysis of partially resected middle turbinates", Laryngoscope, 106(1 Pt 1), pp.102~104 (1996)
21. Giacchi RJ, "Histopathologic evaluation of the ethmoid bone in chronic sinusitis", Am J Rhinol, 15(3), pp.193~197 (2001)
22. Bhandarkar ND, "The impact of osteitis on disease severity measures and quality of life outcomes in chronic rhinosinusitis", Int Forum Allergy Rhinol, 1(5), pp.372~378 (2011)
23. Snidvongs K, "Correlation of the Kennedy Osteitis Score to clinico-histologic features of chronic rhinosinusitis", Int Forum Allergy Rhinol, 3(5), pp.369~375 (2013)
24. Meng Y, "Predictive significance of computed tomography in eosinophilic chronic rhinosinusitis with nasal polyps", Int Forum Allergy Rhinol, 6(8), pp.812~819 (2016)
25. Kong IG, "Receptor activator of nuclear factor κB ligand is a biomarker for osteitis of chronic rhinosinusitis", Int Forum Allergy Rhinol, 10(3), pp.364~373 (2020)
26. Florencio-Silva R, "Biology of bone tissue: structure, function, and factors that influence bone cells", Biomed Res Int, 2015, pp.421746~ (2015)
27. Caetano-Lopes J, "Osteoblasts and bone formation", Acta Reumatol Port, 32(2), pp.103~110 (2007)
28. Metzger CE, "The role of osteocytes in inflammatory bone loss", Front Endocrinol (Lausanne), 10, pp.285~ (2019)
29. Ishino T, "Establishment of osteoblast culture from human ethmoidal sinus", Auris Nasus Larynx, 30(1), pp.45~51 (2003)
30. Stevens PR, "Chronic rhinosinusitis osteoblasts differ in cellular properties from normal bone", Int Forum Allergy Rhinol, 5(2), pp.124~131 (2015)
31. Mehta V, "Blood and sputum eosinophil levels in asthma and their relationship to sinus computed tomographic findings", Mayo Clin Proc, 83(6), pp.671~678 (2008)
32. Gunel C, "Osteitis is associated with P-glycoprotein overexpression in patients with chronic sinusitis without nasal polyps", Am J Rhinol Allergy, 28(2), pp.99~102 (2014)
33. Miyake MM, "P-glycoprotein and chronic rhinosinusitis", World J Otorhinolaryngol Head Neck Surg, 4(3), pp.169~174 (2018)
34. Cheng YS, "Influence of P-glycoprotein function on chronic rhinosinusitis", nasal polyps pathophysiology, 2016, pp.79, 38~47
35. Feldman RE, "P-glycoprotein is a marker of tissue eosinophilia and radiographic inflammation in chronic rhinosinusitis without nasal polyps", Int Forum Allergy Rhinol, 3(8), pp.684~687 (2013)
36. Bleier BS, "P-glycoprotein promotes epithelial T helper 2-associated cytokine secretion in chronic sinusitis with nasal polyps", Int Forum Allergy Rhinol, 4(6), pp.488~494 (2014)
37. Bleier BS, "P-glycoprotein regulates Staphylococcus aureus enterotoxin B-stimulated interleukin-5 and thymic stromal lymphopoietin secretion in organotypic mucosal explants", Int Forum Allergy Rhinol, 6(2), pp.169~177 (2016)
38. Onoe Y, "IL-13 and IL-4 inhibit bone resorption by suppressing cyclooxygenase-2-dependent prostaglandin synthesis in osteoblasts", J Immunol, 156(2), pp.758~764 (1996)
39. Silfversward CJ, "Reduced cortical bone mass in mice with inactivation of interleukin-4 and interleukin-13", J Orthop Res, 25(6), pp.725~731 (2007)
40. Silfversward CJ, "Expression of markers of activity in cultured human osteoblasts: effects of interleukin-4 and interleukin-13", Scand J Clin Lab Invest, 70(5), pp.338~342 (2010)
41. Tuszynska A, "Inflammatory cytokines gene expression in bone tissue from patients with chronic rhinosinusitis: a preliminary study", Rhinology, 48(4), pp.415~419 (2010)
42. Wang M, "Differing roles for TGF-β", Smad signaling in osteitis in chronic rhinosinusitis with and without nasal polyps, 2015, pp.29(5), e152~e159
43. Gunel C, "Microarray analysis of the genes associated with osteitis in chronic rhinosinusitis", Laryngoscope, 127(3), pp.E85~E90 (2017)
44. Jin L, "Growth differentiation factor 5 regulation in bone regeneration", Curr Pharm Des, 19(19), pp.3364~3373 (2013)
45. Sautter NB, "Tissue remodeling gene expression in a murine model of chronic rhinosinusitis", Laryngoscope, 122(4), pp.711~717 (2012)
46. Wu D, "Osteitis is associated with dysregulated pro-osteoblastic activity in patients with nasal polyps", Laryngoscope, 129(3), pp.E102~E109 (2019)
47. Oue S, "Increased IL-13 expression is independently associated with neo-osteogenesis in patients with chronic rhinosinusitis", J Allergy Clin Immunol, 140(5), pp.1444~1448 (2017)
48. Roza Khalmuratova, "Evaluation of Neo-Osteogenesis in Eosinophilic Chronic Rhinosinusitis Using a Nasal Polyp Murine Model", Allergy, Asthma & Immunology Research, 12(2), pp.306~321 (2020), 대한천식알레르기학회
49. Shi N, "Runx2, a novel regulator for goblet cell differentiation and asthma development", FASEB J, 31(1), pp.412~420 (2017)
50. Khalmuratova R, "Interleukin (IL)-13and IL-17A contribute to neo-osteogenesis in chronic rhinosinusitis by inducing RUNX2", EBioMedicine, 46, pp.330~341 (2019)
51. Komori T, "Regulation of bone development and maintenance by Runx2", Front Biosci, 13, pp.898~903 (2008)
52. Jensen ED, "Regulation of gene expression in osteoblasts", Biofactors, 36(1), pp.25~32 (2010)
53. Komori T, "Regulation of bone development and extracellular matrix protein genes by RUNX2", Cell Tissue Res, 339(1), pp.189~195 (2010)
54. Boyce BF, "Functions of RANKL", RANK, Arch Biochem Biophys, pp.2008, 473(2)[DOI]
55. Walsh MC, "Biology of the RANKL-RANK-OPG system in immunity, bone, and beyond", Front Immunol, 5, pp.511~ (2014)
56. Yeo L, "Cytokine mRNA profiling identifies B cells as a major source of RANKL in rheumatoid arthritis", Ann Rheum Dis, 70(11), pp.2022~2028 (2011)
57. Ogasawara N, "Role of RANK-L as a potential inducer of ILC2-mediated type 2 inflammation in chronic rhinosinusitis with nasal polyps", Mucosal Immunol, 13(1), pp.86~95 (2020)
58. Huber C, "In human basophils, IL-3 selectively induces RANKL expression that is modulated by IgER-dependent and IgER-independent stimuli", Allergy, 69(11), pp.1498~1505 (2014)
59. Huang Z, "Clinical predictors of neo-osteogenesis in patients with chronic rhinosinusitis", Int Forum Allergy Rhinol, 5(4), pp.303~309 (2015)
60. Karempelis P, "Risk factors for neo-osteogenesis in cystic fibrosis and non-cystic fibrosis chronic rhinosinusitis", Int Forum Allergy Rhinol, 10(4), pp.505~510 (2020)
61. Dong D, "Correlation between bacterial biofilms and osteitis in patients with chronic rhinosinusitis", Laryngoscope, 124(5), pp.1071~1077 (2014)
62. Zhao YC, "Biofilm and osteitis in refractory chronic rhinosinusitis", Otolaryngol Clin North Am, 50(1), pp.49~60 (2017)
63. Braga AA, "An experimental model of eosinophilic chronic rhinosinusitis induced by bacterial toxins in rabbits", Am J Rhinol Allergy, 33(6), pp.737~750 (2019)
64. Cho DY, "Sinus microanatomy and microbiota in a rabbit model of rhinosinusitis", Front Cell Infect Microbiol, 7, pp.540~ (2018)
65. Shin HW, "Animal models in CRS and pathophysiologic insights gained: a systematic review", Laryngoscope Investig Otolaryngol, 1(5), pp.116~123 (2016)
66. Perloff JR, "Bone involvement in sinusitis: an apparent pathway for the spread of disease", Laryngoscope, 110(12), pp.2095~2099 (2000)
67. Khalid AN, "The role of bone in chronic rhinosinusitis", Laryngoscope, 112(11), pp.1951~1957 (2002)
68. Dong Y, "Computed tomography and histopathological evaluation of osteitis in rabbit models with rhinosinusitis", Acta Otolaryngol, 137(5), pp.534~540 (2017)
69. Khalmuratova R, "Induction of nasal polyps using house dust mite and Staphylococcal enterotoxin B in C57BL", 6 mice, 2016, pp.44(1), 66~75
70. Kim DW, "Staphylococcus aureus enterotoxin B contributes to induction of nasal polypoid lesions in an allergic rhinosinusitis murine model", Am J Rhinol Allergy, 25(6), pp.e255~e261 (2011)
71. Wang S, "Establishment of a mouse model of lipopolysaccharide-induced neutrophilic nasal polyps", Exp Ther Med, 14(6), pp.5275~5282 (2017)
72. Lee M, "Sirtuin 1 attenuates nasal polypogenesis by suppressing epithelial-tomesenchymal transition", J Allergy Clin Immunol, 137(1), pp.87~98 (2016)
73. Lee M, "Sinonasal delivery of resveratrol via mucoadhesive nanostructured microparticles in a nasal polyp mouse model", Sci Rep, 7, pp.40249~ (2017)
74. Kim SW, "Periostin may play a protective role in the development of eosinophilic chronic rhinosinusitis with nasal polyps in a mouse model", Laryngoscope, 123(5), pp.1075~1081 (2013)
75. Khalmuratova R, "Wogonin attenuates nasal polyp formation by inducing eosinophil apoptosis through HIF-1α and survivin suppression", Sci Rep, 8(1), pp.6201~ (2018)
76. Vandamme TF, "Rodent models for human diseases", Eur J Pharmacol, 759, pp.84~89 (2015)
77. Wang Z, "Histological and computed tomographic characteristics of the sinonasal structure of BALB", c mice, 2020, pp.49(2), 222~226
78. Kim SW, "Resveratrol prevents development of eosinophilic rhinosinusitis with nasal polyps in a mouse model", Allergy, 68(7), pp.862~869 (2013)
79. Kim Y, "α-Helical cell-penetrating peptide-mediated nasal delivery of resveratrol for inhibition of epithelial-to-mesenchymal transition", J Control Release, 317, pp.181~194 (2020)

관련 논문AI추천